Bridgeway Capital Management’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $136K | Sell |
|
|||||
|
2025
Q1 | $75.8K | Sell |
|
|||||
|
2024
Q4 | $210K | Sell |
|
|||||
|
2024
Q3 | $685K | Buy |
|
|||||
|
2024
Q2 | $680K | Hold |
|
|||||
|
2024
Q1 | $1.01M | Sell |
|
|||||
|
2023
Q4 | $852K | Hold |
|
|||||
|
2023
Q3 | $922K | Hold |
|
|||||
|
2023
Q2 | $1.1M | Hold |
|
|||||
|
2023
Q1 | $1.17M | Hold |
|
|||||
|
2022
Q4 | $915K | Buy |
|
|||||
|
2022
Q3 | $273K | Sell |
|
|||||
|
2022
Q2 | $623K | Buy |
|
|||||
|
2022
Q1 | $23K | Sell |
|
|||||
|
2021
Q4 | $532K | Sell |
|
|||||
|
2021
Q3 | $575K | Sell |
|
|||||
|
2021
Q2 | $1.7M | Sell |
|
|||||
|
2021
Q1 | $1.51M | Sell |
|
|||||
|
2020
Q4 | $1.2M | Buy |
|
|||||
|
2020
Q3 | $547K | Buy |
|
|||||
|
2020
Q2 | $399K | Sell |
|
|||||
|
2020
Q1 | $438K | Hold |
|
|||||
|
2019
Q4 | $471K | Hold |
|
|||||
|
2019
Q3 | $518K | Hold |
|
|||||
|
2019
Q2 | $582K | Hold |
|
|||||
|
2019
Q1 | $693K | Buy |
|
|||||
|
2018
Q4 | $220K | Buy |
|
|||||
|
2018
Q3 | $448K | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $389K | Hold |
|
|||||
|
2014
Q2 | $378K | Hold |
|
|||||
|
2014
Q1 | $407K | Hold |
|
|||||
|
2013
Q4 | $446K | Hold |
|
|||||
|
2013
Q3 | $470K | Hold |
|
|||||
|
2013
Q2 | $490K | Buy |
|